Jun LiAssociate Director, Upstream Process Development, Gene Therapy at Ultragenyx Pharmaceutical
Jun is currently an Associate Director in Upstream Process Development at Ultragenyx Pharmaceutical Gene Therapy. Her main responsibilities include process lead for gene therapy drug substance process development and manufacturing, manufacturing investigations for early- and late-stage programs, Upstream Process Intensification and platform improvements. Before Ultragenyx, Jun worked at Acceleron Pharma as cell culture group lead for stable cell line development, process development and scale up for more than 20 Fc-Fusion proteins and antibodies. Jun also worked at Bristol Meyers Squib on upstream process development and CUE Biopharma on downstream purification.
Jun graduated from Harvard University with a M.A. degree in Statistics and a Ph.D. in Bioengineering under the supervision of George Church.